—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Tubize-Fin (TUB.BR) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 31 out of 100 (momentum 66 · quality 21 · valuation 22), as of 2026-11-03.
  • Signal: Recovery attempt under the 200-day — Trades +23.1% vs the 50-day and +10.2% vs the 200-day average, 8.8% below the 52-week high and +35.4% off the 52-week low; a death cross printed 61 sessions ago. Computed from daily closes. (as of 2026-11-02)
  • Trend: Tubize-Fin trades 23.1% above its 50-day and 10.2% above its 200-day moving average. (as of 2026-11-02)

Tubize-Fin, formally Financière de Tubize, is a Brussels-based holding company whose main asset is a stake in UCB, a Belgian biopharmaceutical company working on treatments for immune and central-nervous-system disease. Tubize-Fin does not develop or sell drugs itself; its business is holding and managing that UCB position.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the TUB.BR overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +23.1% vs the 50-day and +10.2% vs the 200-day average, 8.8% below the 52-week high and +35.4% off the 52-week low; a death cross printed 61 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the TUB.BR chart & overview · quality & forensics · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on TUB.BR?

Recovery attempt under the 200-day — Trades +23.1% vs the 50-day and +10.2% vs the 200-day average, 8.8% below the 52-week high and +35.4% off the 52-week low; a death cross printed 61 sessions ago. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is TUB.BR above its 50-day and 200-day moving averages?

As of 2026-11-02, Tubize-Fin trades +23.1% above its 50-day and +10.2% above its 200-day average, with the 20-day +18% away.

How far is TUB.BR from its 52-week high?

8.8% below the 52-week high and 35.4% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.